Why Inogen Shareholders Are Having Another Tough Day
After Inogen (NASDAQ: INGN), a medical device company focused on repository care, reported ugly second-quarter results and lowered its guidance, its shares dropped 23% as of 2:12 p.m. EDT on Wednesday.
The headline numbers were pretty unattractive:
Management doesn't see this trend reversing itself anytime soon, either. Revenue is even expected to decline in the third quarter of 2019.
Quelle Fool.com
